Form 6-K SaverOne 2014 Ltd. For: Apr 28
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
For the month of April 2026 (Report No. 2)
Commission file number: 001-41387

SaverOne 2014 Ltd.
(Translation of registrant’s name into English)
Em Hamoshavot Rd. 94
Petah Tikvah, Israel
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
The press release attached to this Form 6-K is hereby incorporated by reference into the registrant’s Registration Statements on Form S-8 (File No. 333-274455) and Form F-3 (File No. 333-274458, 333-263338 and 333-269260), to be a part thereof from the date on which this report is submitted, to the extent not superseded by documents or reports subsequently filed or furnished
CONTENTS
Attached hereto and incorporated herein is the Registrant’s press release issued on April 28, 2026, titled “SaverOne Awarded New European Patent for Mobile Device Classification Using Sensor Fusion”.
1
EXHIBIT INDEX
| Exhibit No. | Description | |
| 99.1 | Press released titled: “SaverOne Awarded New European Patent for Mobile Device Classification Using Sensor Fusion” |
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Date: April 28,2026 | SAVERONE 2014 LTD. | |
| By: | /s/ Ori Gilboa | |
| Name: | Ori Gilboa | |
| Title: | Chief Executive Officer | |
3
ATTACHMENTS / EXHIBITS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- C&C Garage Door and Opener LLC Delivers Trusted Garage Door Installation, Repair, and Emergency Services in Jefferson, GA
- BT1 Dock and Door Strengthens Nashville’s Commercial Facilities with Advanced Loading Dock and Industrial Door Solutions
- Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share